Skip to main content
. 2020 May 25;10:2045125320926347. doi: 10.1177/2045125320926347

Figure 8.

Figure 8.

Number of patients with at least one hospitalization prior to PP3M start and during PP3M treatment (mITT population).

Only patients with both baseline and at least one post-baseline assessment were included in the analysis.

LOCF, last observation carried forward; mITT, modified intent-to-treat; PP3M, paliperidone palmitate 3-month formulation; SR, symptomatic remission.